Analystreport

Orchard Therapeutics plc (NASDAQ: ORTX) had its price target lowered by analysts at Barclays PLC from $6.00 to $4.00.

Orchard Therapeutics plc - American Depositary Shares  (ORTX) 
Last orchard therapeutics plc - american depositary shares earnings: 2/27 07:00 am Check Earnings Report